findmyKOL

Daniel Llano, MD, PhD

Basic profile

Carle Foundation Hospital

ORCIDNPI
RegionUrbana, IL · MidwestSpecialtyNeurologyFocusNeurology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH funding2006–2026Why? →

Daniel Llano is a Neurology physician affiliated with Carle Foundation Hospital. OpenAlex indexes 226 publications with 4,581 citations (h-index 37).

Overview

Scholarship

indexed output and impact (OpenAlex)
226publications

Distinct works indexed by OpenAlex, matched via ORCID.

4,581citations

Total citations across indexed works.

37h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments
12NIH grants · 2006–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

611 W. Park St.
Neurology
Urbana, IL 618012500

Telephone

217-383-3440

Registry record last updated 19 Aug 2014.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    97.9%
    N-methyl-D-aspartate Receptor Antagonist33.3%
    Memantine Hcl97%Memantine Hcl Er3%
    Part D<11 patients
    Cholinesterase Inhibitor26.4%
    Donepezil Hcl92%Rivastigmine8%
    Part D<11 patients

    + 9 more classes in this area

  • Cardiovascular

    2.1%
    Statin1%
    Pravastatin Sodium100%
    Part D<11 patients
    Beta blocker1%
    Propranolol Hcl Er100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

12 NIH research awards on record, funded 20062026 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”